胃排空延迟识别系统性硬化症高危临床亚组
35%患者存在胃动力障碍,其与间质性肺病、食管收缩缺失及抗U1RNP抗体相关,且独立预测SSc相关死亡和/或肺移植复合终点。
要点
- SSc患者中胃动力障碍患病率35%,与间质性肺病和食管收缩缺失相关。
- 胃动力障碍者抗U1RNP抗体更常见,抗着丝点抗体较少见。
- 胃动力障碍独立预测SSc相关死亡和/或肺移植(校正后HR=4.23)。
核心结论
- 在SSc中,胃动力障碍与独特的临床和血清学表型相关,并独立预测严重不良结局。
主要发现
- 33例(35%)患者存在胃动力障碍。
- 胃动力障碍患者间质性肺病患病率63.6% vs 30.3%(P=0.033),食管收缩缺失75.8% vs 45.9%(P<0.001)。
- 胃动力障碍在抗着丝点抗体阳性者中较少见(27.3% vs 55.0%,P=0.009),在抗U1RNP抗体阳性者中更常见(15.6% vs 1.7%,P=0.011)。
- 随访期间16例(17.0%)发生SSc相关死亡和/或肺移植复合终点。
- 未校正Cox回归中胃动力障碍与不良结局强相关(HR=6.47,95%CI:2.09-20.10,P=0.001),校正混杂因素后仍显著(HR=4.23,95%CI:1.25-14.33,P=0.020)。
关键数值与推荐
- 胃动力障碍定义为4小时胃排空显像胃残留≥20%。
临床怎么用
- 对SSc患者进行客观胃功能评估可能有助于风险分层,识别高危亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the prevalence of objectively defined gastric dysmotility in SSc and to evaluate its associations with SSc clinical and immunological features and adverse outcomes (SSc-related death and/or lung transplantation). METHODS: We conducted a retrospective cohort study. All participants underwent a standardized 4-h solid gastric emptying scintigraphy. Gastric dysmotility was defined as ≥20% gastric retention at 4-h. We examined associations between gastric dysmotility and demographic, clinical and immunologic characteristics of SSc, as well as relevant clinical outcomes. RESULTS: Ninety-four patients were included (mean age 48 ± 12 years; 81% female). Gastric dysmotility was identified in 33 patients (35%). Patients with gastric dysmotility had a higher prevalence of interstitial lung disease (63.6% vs 30.3%, P = 0.033) and absent oesophageal contractility (75.8% vs 45.9%, P < 0.001) compared with those without. Gastric dysmotility was less frequent in patients with ACAs (27.3% vs 55.0%, P = 0.009) but more common in those with anti-U1RNP antibodies (15.6% vs 1.7%, P = 0.011). During follow-up (mean duration 2.8 ± 1.7 years; 260 person-years), 16 patients (17.0%) experienced the composite end point of SSc-related death and/or lung transplantation. In unadjusted Cox regression, gastric dysmotility was strongly associated with adverse outcomes (HR = 6.47, 95% CI: 2.09-20.10, P = 0.001), which remained significant after adjustment for confounders (HR = 4.23, 95% CI: 1.25-14.33, P = 0.020). CONCLUSIONS: In SSc, we have confirmed that gastric dysmotility is associated with a distinct clinical and serological phenotype and that it independently predicts serious adverse outcomes. These findings underscore the importance of objective assessment of gastric function and its potential role in risk stratification.
引用
- Felix-Tellez FA, Guillen-Del-Castillo A, Pedroza C, et al. Delayed gastric emptying identifies a high-risk clinical subgroup in patients with systemic sclerosis. Rheumatology (Oxford). 2026. PMID: 41649461. doi:10.1093/rheumatology/keag070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。